Delivery Order SPE2DB22D9330-SPE2DB25FK8KY

Award Date 10/10/24
Potential Completion Date 11/1/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,436.28 contract is for the supply of the contraceptive device KYLEENA 19.5MG SYS 1S, with a period of performance through April 21, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,024.70 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $5,868.00 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS to support the recurring medical supply needs of military health facilities. The contract has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,969.65 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device. The contract is not associated with a set-aside program and has an ultimate completion date of October 8, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a $4,815.36 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,347.24, is a firm fixed-price delivery order for the supply of a pharmaceutical product, specifically the contraceptive device KYLEENA 19.5 MG SYSTEMS. The contract has an ultimate completion date of August 28, 2024. This award is part of a larger indefinite delivery contract...
This contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the delivery of the contraceptive device Kyleena 19.5 mg Systems. The award, valued at $2,419.76, was made by the Defense Logistics Agency (DLA) on May 24, 2024 as a firm fixed-price delivery order. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,757.76 contract is for the delivery of the contraceptive device KYLEENA 19.5 MG SYSTEMS and has an ultimate completion date of January 5, 2024. DMS Pharmaceutical Group Inc. also holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,957.52 contract is for the supply of the contraceptive device Kyleena 19.5 mg Systems to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,239.20 contract is for the delivery of the contraceptive device Kyleena 19.5 mg systems. The award has a completion date of February 15, 2024 and is not associated with any set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract...
  • SPE2DB22D9330
    Indefinite Delivery Contract
  • SPE2DB22D9330-SPE2DB25FK8KY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,209.88 firm fixed-price delivery order is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS, with a period of performance through November 1, 2024.

DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical products to support the medical supply needs of Department of Defense healthcare facilities worldwide. This specific delivery order is not designated as a set-aside contract. DMS Pharmaceutical Group is the sole prime contractor on this award.

Generated 1/9/25, 9:23 AM